Update on targeted cancer therapies, single or in combination, and their fine tuning for precision medicine

by Sara S Bashraheel, Alexander Domling, Sayed K Goda
Published 2020-05-01

Bio-vehicles of cytotoxic drugs for delivery to tumor specific targets for cancer precision therapy

by Layla Al-mansoori, Philip Elsinga, Sayed K. Goda
Published 2021-12-01

Strategies for the production of long-acting therapeutics and efficient drug delivery for cancer treatment

by Alanod D. AlQahtani, David O’Connor, Alexander Domling, Sayed K. Goda
Published 2019-05-01

Isolation and molecular characterization of novel glucarpidases: Enzymes to improve the antibody directed enzyme pro-drug therapy for cancer treatment.

by Fatma B Rashidi, Alanod D AlQhatani, Sara S Bashraheel, Shabnam Shaabani, Matthew R Groves, Alexander Dömling, Sayed K Goda
Published 2018-01-01

Studies on vascular response to full superantigens and superantigen derived peptides: Possible production of novel superantigen variants with less vasodilation effect for tolerable...

by Sara S. Bashraheel, Alanod D. AlQahtani, Fatma B. Rashidi, Haya Al-Sulaiti, Alexander Domling, Nelson N. Orie, Sayed K. Goda
Published 2019-07-01

Production of “biobetter” variants of glucarpidase with enhanced enzyme activity

by Alanod D. Al-Qahtani, Sara S. Bashraheel, Fatma B. Rashidi, C. David O’Connor, Atilio Reyes Romero, Alexander Domling, Sayed K. Goda
Published 2019-04-01